Taking into account all aspects of radiopharmacy and radiotherapeutic equipment, it is clear that the entire supply chain, and therefore the complete value chain, is represented in Belgium: from the production of the radionuclides, followed by the radiopharmaceuticals production, up to the diagnostic and therapeutic applications in healthcare centres for the patients, including activities related to X-rays and proton therapy equipment.
Our reactors are able to produce, at a large scale and under GMP conditions, different radionuclides and will be able to produce many new ones in the future. All the expertise for the development and the manufacturing of cyclotrons is available in Belgium, and full solutions of turnkey systems for the manufacturing of radiopharmaceuticals (for PET, SPECT and therapeutic applications) are also present in the country. Together with these production sites, Belgium has an important network of healthcare centres providing the full spectra of services in diagnostics and imaging, including clinical research activities and all the associated expertise in physics as well as in medicine present in the different renowned universities in the country.
Next to the radiopharmacy activities, Belgium hosts the number one company worldwide in proton therapy and hadron therapy including its development and manufacturing centre. Many of these activities are obviously performed under GMP conditions and are fully in line with ALARP regulations. Complementary services linking all these partners should not be forgotten as, with their expertise linked to transport, nuclear safety or waste management, they complete this value chain.
Thanks to their training centres and their study programs, industries and universities provide a full range of education at every stage of the value chain. This is the same for research and development activities, activities that complete the whole picture, creating an integrated value chain with utmost interest for any partner looking for a global proposal.